series-a
Stage
1
Investors
About
Develops precision, needle-free pulmonary drug delivery devices (a handheld inhaler platform) designed to deliver biologics, vaccines, and other therapeutics through the lungs. The company focuses on engineered hardware and delivery systems for systemic drug administration without needles.
Explore Portal Instruments's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.